646 | ZANUBRUTINIB PLUS R‐CHOP IMPROVES THE TREATMENT EFFECT OF NEWLY DIAGNOSED DIFFUSE LARGE B CELL LYMPHOMA WITH DOUBLE EXPRESSION OF MYC AND BCL‐2

Documenti analoghi

• 284 | NOVEL ZCR (ZANUBRUTINIB, CHIDAMIDE, RITUXIMAB) ± CHOP REGIMEN DEMONSTRATES PROMISING EFFICACY IN FRONTLINE TREATMENT OF DOUBLE‐EXPRESSOR DIFFUSE LARGE B‐CELL LYMPHOMA
  di: Z. Li, et al.
  Pubblicazione: (2025)
• 675 | A COMBINED EASIX‐IPI SCORE IMPROVES THE PROGNOSTIC STRATIFICATION OF NEWLY DIAGNOSED DIFFUSE LARGE B‐CELL LYMPHOMA
  di: J. Y. Tan, et al.
  Pubblicazione: (2025)
• 644 | EFFICACY OF ZANUBRUTINIB IN NEWLY DIAGNOSED MYD88‐MUTATED DIFFUSE LARGE B‐CELL LYMPHOMA: A RETROSPECTIVE SINGLE‐CENTER REAL‐WORLD STUDY
  di: W. Huang, et al.
  Pubblicazione: (2025)
• 627 | PROMISING OUTCOMES WITH POLA‐R‐CHP IN NEWLY DIAGNOSED DIFFUSE LARGE B CELL LYMPHOMA WITH BULKY DISEASE
  di: Z. Jiang, et al.
  Pubblicazione: (2025)
• 154 | CLINICAL IMPACT OF UNTARGETED BASELINE PLASMA METABOLOMICS IN NEWLY DIAGNOSED DIFFUSE LARGE B CELL LYMPHOMA
  di: R. Dondolin, et al.
  Pubblicazione: (2025)